A positive oscillatory expiratory air pressure respiratory therapy device which is adapted to receive a nebulizer for administering aerosolized medicant for selective administration during oscillatory positive expiratory pressure (PEP) therapy.Richards, Fredrick M....
PEPAXTO is indicated in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38...
Postoperation respiratory failure 16 (9%) other diseases 19 (10%) as: ADEM(2), sdr Guillain Barre (3), acute obstruction of the airway (11),diaphragmatocele (1) , post traumatical contusion of the lungs (1), rabdomyolisis(1). Therapy: Oxygen therapy were given 82(45%) children, ...
Exclusion criteria include: primary diagnosis of a respiratory condition other than bronchiectasis, breath- ing through an artificial airway or requiring non-invasive ventilation within 48 h of hospital admission, or any contraindication to ACBT or O-PEP therapy, including Phillips et al. BMC...
5 Over time, the condition leads to loss of mobility, respiratory complications, and heart issues. While there is no cure, treatments like physical therapy, medications, and emerging therapies aim to slow progression and improve quality of life. Newer therapies like PGN-EDO51 that target exon ...
Toxicity and tolerability of Fluoroquinolone-based preventive therapy for childhood contacts of multidrug-resistant tuberculosis. Pediatr Infect Dis J. 2014;33: 1098–9. https://doi.org/10.1097/inf.0000000000000369. 52. Yawalkar SJ, Mcdougall AC, Languillon J, Ghosh S, Hajra SK, Opromolla ...
PEPAXTO is indicated in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38...
Mean nasopharyngeal pressure during high-flow oxygen therapy, with mouth open or closed. Mean nasopharyngeal pressure during high-flow oxygen therapy,
Background: Upper respiratory tract infections (URTIs) account for at least half of all acute illnesses. Specific antiviral therapy has not been developed ... Youichi,Yanagawa,and,... - 《Current Therapeutic Research》 被引量: 26发表: 2004年 A study of the shaping of the ‘emotion and atti...
A respiratory therapy device has both a standard positive expiratory pressure (PEP) device and an oscillatory PEP device packaged together. A manually operable member is movable to